Tech Company Financing Transactions
Perpetual Medicines Funding Round
Chengwei Ventures participated in a $8 million Seed capital raise for Perpetual Medicines. The round was announced on 11/30/2023.
Transaction Overview
Company Name
Announced On
11/30/2023
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to advance its integrated computational design and synthesis platform for peptide drug discovery.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Room A1312, Floor 13, Building 3 No. 702 Zhongke Road
Shanghai, Undisclosed
CN
Shanghai, Undisclosed
CN
Phone
Undisclosed
Website
Email Address
Overview
Perpetual Medicines is a fully integrated computational peptide therapeutics firm aiming to develop the next-generation peptide drug discovery engine. To anticipate many peptide properties with high accuracy, Perpetual Medicines' platform will combine cutting-edge computational physics methodologies such as MD modeling, FEP, and quantumchemistry with next-generation AI technologies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kerry BLANCHARD
Chief Technical Officer
Ved SRIVASTAVA
Browse more venture capital transactions:
Prev: 11/30/2023: Aviz Networks venture capital transaction
Next: 11/30/2023: Malta venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs